Literature DB >> 3930960

The thrombolysis in myocardial infarction (TIMI) trial.

W Ganz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3930960     DOI： 10.1056/NEJM198510173131611

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  A Nomogram model for predicting the occurrence of no-reflow phenomenon after percutaneous coronary intervention using the lncRNA TUG1/miR-30e/NPPB biomarkers.

Authors:  Chen-Kai Hu; Ru-Ping Cai; Lei He; Shi-Rong He; Jun-Yu Liao; Qiang Su
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Modified subintimal plaque modification improving future recanalization of chronic total occlusion percutaneous coronary intervention.

Authors:  Ruo-Fei Jia; Long Li; Yong Zhu; Cheng-Zhi Yang; Shuai Meng; Yang Ruan; Xiao-Jing Cao; Hong-Yu Hu; Wei Chen; Jing Nan; Xiao-Wei Xiong; Jing-Jin Li; Jia-Yu Wang; Ze-Ning Jin
Journal:  J Geriatr Cardiol       Date:  2020-07-28       Impact factor: 3.327

3.  Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke.

Authors:  Masoud Mehrpour; Mahboubeh Aghaei; Mohammad Reza Motamed
Journal:  Med J Islam Repub Iran       Date:  2013-08

4.  Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients.

Authors:  Jing Wei Li; Yun Dai Chen; Wei Ren Chen; Jing Jing; Jie Liu; Yong Qiang Yang
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

5.  Stenting versus non-stenting treatment of intermediate stenosis culprit lesion in acute ST-segment elevation myocardial infarction: a multicenter randomized clinical trial.

Authors:  Jing Dai; Shu-Zheng Lyu; Yun-Dai Chen; Xian-Tao Song; Min Zhang; Wei-Min Li; Yang Zheng; Shang-Yu Wen; Shao-Ping Nie; Yu-Jie Zeng; Hai Gao; Yi-Tong Ma; Shu-Yang Zhang; Li-Jun Guo; Zheng Zhang
Journal:  J Geriatr Cardiol       Date:  2017-02       Impact factor: 3.327

6.  The impact of a single episode of remote ischemic preconditioning on myocardial injury after elective percutaneous coronary intervention.

Authors:  Mustafa A Yılmaztepe; Gökay Taylan; Meryem Aktoz; Hanefi Y Gürlertop; Yüksel Aksoy; Fatih Özçelik; Kenan Yalta; Galip Ekuklu
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

7.  The safety of morphine use in acute coronary syndrome: a meta-analysis.

Authors:  Rugheed Ghadban; Tariq Enezate; Joshua Payne; Haytham Allaham; Ahmad Halawa; Hee Kong Fong; Obai Abdullah; Kul Aggarwal
Journal:  Heart Asia       Date:  2019-03-19

8.  Effects of different strategies on high thrombus burden in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary catheterization.

Authors:  Yuyang Xiao; Xianghua Fu; Yanbo Wang; Yanming Fan; Yanqiang Wu; Wenlu Wang; Qian Zhang
Journal:  Coron Artery Dis       Date:  2019-12       Impact factor: 1.439

9.  Predicting coronary no-reflow in patients with acute ST-segment elevation myocardial infarction using Bayesian approaches.

Authors:  Dongfeng Zhang; Xiantao Song; Shuzheng Lv; Dong Li; Shuai Yan; Min Zhang
Journal:  Coron Artery Dis       Date:  2014-11       Impact factor: 1.439

10.  COVID-19 pandemic and STEMI: pathway activation and outcomes from the pan-London heart attack group.

Authors:  Callum D Little; Tushar Kotecha; Luciano Candilio; Richard J Jabbour; George B Collins; Asrar Ahmed; Michelle Connolly; Ritesh Kanyal; Ozan M Demir; Lucy O Lawson; Brian Wang; Sam Firoozi; James C Spratt; Divaka Perera; Philip MacCarthy; Miles Dalby; Ajay Jain; Simon J Wilson; Iqbal Malik; Roby Rakhit
Journal:  Open Heart       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.